Jundishapur Journal of Microbiology

Published by: Kowsar

Antiviral Activity of Thiazolide Derivatives Against Dengue Virus in Huh-7 Cell Line

Farkhanda Yasmin 1 , Tahir Yaqub 1 , * , Idrees Khan 2 , Wasim Shahzad 1 , Abu Saeed Hashmi 1 , Zarfishan Tahir 1 , 3 , Nadia Mukhtar 1 and Sajid Umar 4
Authors Information
1 Institute of Biochemistry and Biotechnology, University of Veterinary and Animal Sciences, Lahore, Pakistan
2 Department of Microbiology, University of Veterinary and Animal Sciences, Lahore, Pakistan
3 National Centre of Excellence in Molecular Biology, Lahore, Pakistan
4 Department of Pathobiology, PMAS Arid Agriculture University Rawalpindi, Pakistan
Article information
  • Jundishapur Journal of Microbiology: February 2018, 11 (2); e62467
  • Published Online: November 30, 2017
  • Article Type: Research Article
  • Received: April 14, 2017
  • Revised: October 7, 2017
  • Accepted: November 5, 2017
  • DOI: 10.5812/jjm.62467

To Cite: Yasmin F, Yaqub T, Khan I, Shahzad W, Saeed Hashmi A, et al. Antiviral Activity of Thiazolide Derivatives Against Dengue Virus in Huh-7 Cell Line, Jundishapur J Microbiol. 2018 ; 11(2):e62467. doi: 10.5812/jjm.62467.

Abstract
Copyright © 2017, Jundishapur Journal of Microbiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
6. Conclusions
Acknowledgements
Footnotes
References
  • 1. Yang CC, Tsai MH, Hu HS, Pu SY, Wu RH, Wu SH, et al. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus. Antiviral Res. 2013;98(2):228-41. doi: 10.1016/j.antiviral.2013.03.001.
  • 2. Das S, Pingle MR, Munoz-Jordan J, Rundell MS, Rondini S, Granger K, et al. Detection and serotyping of dengue virus in serum samples by multiplex reverse transcriptase PCR-ligase detection reaction assay. J Clin Microbiol. 2008;46(10):3276-84. doi: 10.1128/JCM.00163-08. [PubMed: 18685000].
  • 3. Bazan JF, Fletterick RJ. Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. Virology. 1989;171(2):637-9. [PubMed: 2548336].
  • 4. Gibbons RV, Vaughn DW. Dengue: an escalating problem. BMJ. 2002;324(7353):1563-6. [PubMed: 12089096].
  • 5. Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480-96. [PubMed: 9665979].
  • 6. Leardkamolkarn V, Srigulpanit W, Phurimsak C, Kumkate S, Himakoun L, Sripanidkulchai B. The inhibitory actions of Houttuynia cordataaqueous extract on dengue virus and dengue-infected cells. J Food Biochem. 2012;26:86-92.
  • 7. Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ. Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep. 2010;12(3):157-64. doi: 10.1007/s11908-010-0102-7. [PubMed: 21308524].
  • 8. Jahan F. Dengue Fever (DF) in Pakistan. Asia Pac Fam Med. 2011;10(1):1. doi: 10.1186/1447-056X-10-1. [PubMed: 21349169].
  • 9. Khan E, Kisat M, Khan N, Nasir A, Ayub S, Hasan R. Demographic and clinical features of dengue fever in Pakistan from 2003-2007: a retrospective cross-sectional study. PLoS One. 2010;5(9):12505. doi: 10.1371/journal.pone.0012505. [PubMed: 20856935].
  • 10. Bollati M, Alvarez K, Assenberg R, Baronti C, Canard B, Cook S, et al. Structure and functionality in flavivirus NS-proteins: perspectives for drug design. Antiviral Res. 2010;87(2):125-48. doi: 10.1016/j.antiviral.2009.11.009. [PubMed: 19945487].
  • 11. Korba BE, Montero AB, Farrar K, Gaye K, Mukerjee S, Ayers MS, et al. Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antiviral Res. 2008;77(1):56-63. doi: 10.1016/j.antiviral.2007.08.005. [PubMed: 17888524].
  • 12. Shum D, Smith JL, Hirsch AJ, Bhinder B, Radu C, Stein DA, et al. High-content assay to identify inhibitors of dengue virus infection. Assay Drug Dev Technol. 2010;8(5):553-70. doi: 10.1089/adt.2010.0321. [PubMed: 20973722].
  • 13. Fatima Z, Idrees M, Bajwa MA, Tahir Z, Ullah O, Zia MQ, et al. Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiol. 2011;11:200. doi: 10.1186/1471-2180-11-200. [PubMed: 21906394].
  • 14. Hsu YC, Chen NC, Chen PC, Wang CC, Cheng WC, Wu HN. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Arch Virol. 2012;157(4):681-8. doi: 10.1007/s00705-012-1224-z. [PubMed: 22249364].
  • 15. Masse N, Davidson A, Ferron F, Alvarez K, Jacobs M, Romette JL, et al. Dengue virus replicons: production of an interserotypic chimera and cell lines from different species, and establishment of a cell-based fluorescent assay to screen inhibitors, validated by the evaluation of ribavirin's activity. Antiviral Res. 2010;86(3):296-305. doi: 10.1016/j.antiviral.2010.03.010. [PubMed: 20307577].
  • 16. Qing M, Liu W, Yuan Z, Gu F, Shi PY. A high-throughput assay using dengue-1 virus-like particles for drug discovery. Antiviral Res. 2010;86(2):163-71. doi: 10.1016/j.antiviral.2010.02.313. [PubMed: 20153777].
  • 17. Noble CG, Chen YL, Dong H, Gu F, Lim SP, Schul W, et al. Strategies for development of Dengue virus inhibitors. Antiviral Res. 2010;85(3):450-62. doi: 10.1016/j.antiviral.2009.12.011. [PubMed: 20060421].
  • 18. Wengler G. The carboxy-terminal part of the NS 3 protein of the West Nile Flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase. Virology. 1991;184(2):707-15. doi: 10.1016/0042-6822(91)90440-m.
  • 19. Rai MA. Epidemic: Control of dengue fever in Pakistan. Nature. 2011;479(7371):41. doi: 10.1038/479041d. [PubMed: 22051664].
  • 20. Lim SP, Wang QY, Noble CG, Chen YL, Dong H, Zou B, et al. Ten years of dengue drug discovery: progress and prospects. Antiviral Res. 2013;100(2):500-19. doi: 10.1016/j.antiviral.2013.09.013. [PubMed: 24076358].
  • 21. Warrener P, Tamura JK, Collett MS. RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. J Virol. 1993;67(2):989-96. [PubMed: 8380474].
  • 22. Gorbalenya AE, Donchenko AP, Koonin EV, Blinov VM. N-terminal domains of putative helicases of flavi- and pestiviruses may be serine proteases. Nucleic Acids Res. 1989;17(10):3889-97. [PubMed: 2543956].
  • 23. Lindenbach BD, Pragai BM, Montserret R, Beran RK, Pyle AM, Penin F, et al. The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication. J Virol. 2007;81(17):8905-18. doi: 10.1128/JVI.00937-07. [PubMed: 17581983].
  • 24. Murray CL, Jones CT, Rice CM. Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol. 2008;6(9):699-708. doi: 10.1038/nrmicro1928. [PubMed: 18587411].
  • 25. Paul D, Bartenschlager R. Architecture and biogenesis of plus-strand RNA virus replication factories. World J Virol. 2013;2(2):32-48. doi: 10.5501/wjv.v2.i2.32. [PubMed: 24175228].
  • 26. Rothan HA, Zulqarnain M, Ammar YA, Tan EC, Rahman NA, Yusof R. Screening of antiviral activities in medicinal plants extracts against dengue virus using dengue NS2B-NS3 protease assay. Trop Biomed. 2014;31(2):286-96. [PubMed: 25134897].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments